Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Neoplasms 1Lung Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Carcinoma, Renal Cell 1

Interventions

Nivolumab 22Specimen Handling 17pembrolizumab 13cabozantinib 13Magnetic Resonance Spectroscopy 13belzutifan 12Ipilimumab 12lenvatinib 7Axitinib 7CTLA-4 Antigen 6Biopsy 6atezolizumab 4Sunitinib 4tivozanib 3Surveys and Questionnaires 3Immunoglobulin G 3Everolimus 3Disulfides 3relatlimab 2pazopanib 2palbociclib 2aldesleukin 2Watchful Waiting 2Standard of Care 2Radiosurgery 2Practice Guidelines as Topic 2Nephrectomy 2Bevacizumab 2zimberelimab 1ulixertinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Renal Cell × Tyrosine Kinase Inhibitors × 30 days × Clear all
NCT04777994 2026-06-04

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Calico Life Sciences LLC

Phase 1 Recruiting
248 enrolled
GenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡